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Chromatin assembly factor I (CAF-I) is a multisub- 
unit protein complex purified from the nuclei of human 
cells and required for chromatin assembly during DNA 
replication in uitro. Purified CAF-I promotes chro- 
matin assembly in a reaction that is dependent upon, 
and coupled with, DNA replication and is therefore 
likely to reflect  events that occur during S phase in 
vivo. In  order  to investigate the regulation and mech- 
anism of CAF-I and the replication-dependent chro- 
matin assembly process, we have used the purified 
protein to raise monoclonal antibodies. In this report 
we describe the characterization of a panel of  mono- 
clonal antibodies which recognize different subunits of 
the CAF-I complex. We use immunoprecipitation 
analysis to show that CAF-I exists as a multiprotein 
complex in  vivo and that some of the polypeptides are 
phosphorylated. In addition, immunocytochemistry 
demonstrates that CAF-I is localized to the nucleus of 
human cells. Finally, monoclonal antibodies directed 
against the individual subunits of CAF-I immunode- 
plete chromatin assembly activity from nuclear ex- 
tracts, confirming that CAF-I is a multisubunit protein 
required for chromatin assembly in  vitro. 
During each cell cycle not only must all of the DNA in the 
cell be replicated, but, in addition, the protein structure of 
chromatin must be accurately reproduced. In S phase,  during 
DNA replication, there is not a protracted period of time 
where DNA is free of nucleosomes, suggesting that chromatin 
assembly is tightly coupled to DNA replication i n  vivo 
(McKnight  and Miller (1977); reviewed in DePamphilis  and 
Bradley (1986)). Very little is known, however, about the 
molecular mechamism of chromatin assembly during DNA 
replication. To investigate this process, we have used the well 
characterized cell-free system for SV40  DNA replication (for 
recent reviews see Stillman (1989) and Chalberg and Kelly 
(1989)). 
SV40 serves as  a good model system for the replication and 
assembly of mammalian chromosomes, since, aside from the 
virally encoded large T antigen,  all of the proteins required 
for the replication of the viral DNA and its assembly into  a 
chromosome are provided by the host cell (reviewed in De- 
Pamphilis and Bradley (1986)). In the cell-free system, a 
crude cytosol extract from human cells plus purified SV40 T 
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antigen supports the replication of SV40 origin-containing 
plasmid DNA (Li and Kelly, 1984,  1985; Stillman  and Gluz- 
man, 1985; Wobbe et al., 1985). The addition of a nuclear 
extract promotes assembly of the replicating DNA into a 
chromatin  structure resembling chromatin found in vivo 
(Stillman, 1986). Biochemical fractionation of the nuclear 
extract  has resulted in the identification of a single component 
that is required for chromatin assembly (Smith  and  Stillman, 
1989). This activity was purified from human cells as a 
multisubunit  protein complex called chromatin assembly fac- 
tor I, CAF-1’ (Smith  and Stillman, 1989). Purified CAF-I will 
substitute for the crude nuclear extract in the chromatin 
assembly reaction described above. Chromatin assembly by 
CAF-I is dependent upon DNA replication and is therefore 
likely to reflect the process of chromatin assembly that occurs 
during DNA replication in vivo. 
To begin to elucidate the mechanism and regulation of 
CAF-I, the purified protein was used to raise monoclonal 
antibodies. In  this  report,  the  characterization of a panel of 
these monoclonal antibodies which recognize individual sub- 
units of the CAF-I complex is described. These results confirm 
that CAF-I is indeed a multiprotein complex but further 
demonstrate that it is a nuclear phosphoprotein that is essen- 
tial for chromatin assembly in uitro. 
MATERIALS AND  METHODS 
Monoclonal  Antibodies-A  highly purified fraction of CAF-I, pre- 
pared as described previously (Mono Q,  fraction 6 of the purification, 
Smith and  Stillman (1989)), was used to immunize a BALB/c mouse. 
The mouse was immunized three times during a four week period 
with purified CAF-I antigen (5 pg of each CAF-I polypeptide per 
injection) in complete Freund’s adjuvant (primary injection) or in- 
complete Freund‘s adjuvant (subsequent injections),  intraperito- 
neally. This was  followed by two injections (one  intraperitoneal  and 
the other intravenous) of 5 pg each of purified CAF-I antigen in 
phosphate-buffered saline (PBS).  Three days later the spleen cells 
were fused (Kohler and Milstein, 1975) with mouse myeloma cells, 
NSI/Ag4-1 (Kohler  et al., 1976). Hybridoma clones were selected in 
hypoxanthine/azaserine medium. Hybridoma supernatants were ini- 
tially screened for their ability to bind to purified CAF-I antigen 
which had been immobilized onto nitrocellulose using a dot blot 
procedure (Hawkes, 1986). The second and third screens were for 
those antibodies that recognized CAF-I polypeptides in an immuno- 
blotting analysis (described below) using purified CAF-I antigen and/ 
or  those that could immunoprecipitate CAF-I polypeptides from (35S] 
methionine-labeled cells under the denaturing conditions described 
below. The clones of interest were subcloned by the method of limiting 
dilution and single cell cloning. The monoclonal antibodies were 
isotyped using the commercially available kit (Baxter Health Care 
Corp., Pandex Division, Mundelein, IL). All the monoclonal antibod- 
ies characterized were  mouse IgG1.. 
’ The abbreviations used are: CAF-I, chromatin assembly factor I; 
mAb, monoclonal antibody; PBS, phosphate-buffered saline; SDS, 
sodium dodecyl sulfate. 
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The monoclonal antibodies used as controls in the experiments 
were:  pAb  419, a monoclonal antibody directed against SV40 T 
antigen, previously called L19 (Harlow et al., 1981); mAb p70-9, a 
monoclonal antibody directed against  a 70-kDa polypeptide in repli- 
cation factor A  (Fairman and Stillman, 1988; Din et al., 1990); and 
mAb  1644, a monoclonal antibody against human DNA polymerase 
CY, originally designated as  SJK 287-38 (Tanaka et al., 1982). 
A polyclonal mouse antiserum against CAF-I was obtained by 
bleeding the hyperimmune mouse (described above), after removing 
the spleen. 
Zmrnunoblotting-protein samples were subjected to SDS-poly- 
acrylamide gel electrophoresis according to  the procedure of Laemmli 
(19701, and  transferred to nitrocellulose using a dry electroblotting 
apparatus (American Bionetics Inc., Emeryville, CA).  All incubations 
were carried out at room temperature. Nitrocellulose filters were 
blocked for 60 min in 3% bovine serum albumin (w/v) in pre-coat 
buffer (10 mM NaP04, pH 7.4, 150 mM NaCl, and 0.5% Nonidet P- 
40). Filters were incubated overnight with hybridoma supernatants 
and then washed in pre-coat buffer for 15 min, followed  by a 15-min 
wash in buffer containing  2 M urea, 1% Nonidet P-40, and 100 mM 
glycine, and two more 15-min washes in pre-coat buffer. Nitrocellu- 
lose filters were then incubated with a 1:200 dilution of rabbit anti- 
mouse horseradish peroxidase-conjugated immunoglobulins (Dako 
Corporation, Carpinteria, CA), for 2 h. Filters were then washed three 
times for 15 min each in pre-coat buffer, followed by three 5-min 
washes in  PBS. The second antibody was detected by incubation of 
the filters with a developing solution prepared as follows. A  saturated 
solution of o-dianisidine (Sigma) in  ethanol was prepared. This was 
diluted 1:lOO into  PBS, and HzOz (30%) was added (1:10,000). 
Cell Culture-HeLa cells and 293 cells were grown at  37 "C as 
subconfluent monolayer cultures  on 100-mm tissue culture  plates  in 
Dulbecco's  modified Eagles medium supplemented with 5% fetal calf 
serum or 10% calf serum, respectively. 
Cell Staining-Immunocytochemistry was performed on HeLa 
cells. All incubations were done at room temperature. Cells were 
formaldehyde-fixed by incubation in 3.7% formaldehyde for 15 min 
followed by permeabilization with 0.2% Triton X-100 for 2 min. Cells 
were methanol/acetone-fixed by incubation in  a solution containing 
50% methanol, 50% acetone for 5 min. Fixed cells were incubated 
overnight with hybridoma supernatants  and rinsed several times with 
PBS, followed by a 2-h incubation with a 1:200 dilution of rabbit 
anti-mouse horseradish peroxidase-conjugated immunoglobulins 
(Dako Corporation). The second antibody was detected as described 
above for the immunoblotting procedure. 
Labeling of 293 Cells-293 cells were preincubated in  methionine- 
free Dulbecco's modified Eagle's medium supplemented with 2% 
dialyzed calf serum for 30 min at 37 "C. Cells were then labeled for 4 
h at 37 "C with 500 pCi of ["5S]methionine (Translabel, ICN Radi- 
ochemicals, Irvine, CA) in 1 ml of the same medium per 100-mm 
dish. For "P-labeling, 293 cells were preincubated in phosphate-free 
Dulbecco's  modified Eagle's medium supplemented with 2% dialyzed 
calf serum for 30 min at 37 "C. Cells were then labeled for 4 h at 
37 "C with 1 mCi  of [32P]orthophosphate in 1 ml of the same medium 
per 100-mm dish. The labeled cells were  lysed, and immunoprecipi- 
tations were performed as described below. 
Irnmunoprecipitation-["'S]Methionine- or [32P]phosphate-labeled 
human 293 cells were washed three  times with PBS, scraped with a 
rubber policeman, and collected by Centrifugation. For denaturing 
conditions, cells were  lysed with 500 p1 of RIPA buffer (50 mM Tris, 
pH 8.0, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 150 mM 
NaC1, and 1 mM phenylmethylsulfonyl fluoride), for each 100-mm 
dish. The sample was incubated on ice for 10 min with 50 pl of a 
solution containing 0.5 M Tris,  pH 7.2,  50 mM MgCL,  0.5  mg/ml RN- 
ase, and 1.0 mg/ml DNase. Cells were homogenized through a 25- 
gauge syringe needle and cleared by centrifugation. Immunoprecipi- 
tations were carried out by incubating the cell lysate with 200 p1 of 
monoclonal antibody supernatant for 60 min on ice, followed by 
incubation with 1 p1 of rabbit anti-mouse immunoglobulins (Dako 
Corporation) on ice for 30 min. The samples were then cleared of 
debris by centrifugation. The immunocomplex was precipitated after 
incubation with 50 p1 of 1:l slurry of protein A-Sepharose (Pharmacia 
LKB Biotechnology Inc.) in RIPA buffer. Complexes were washed 
six times with RIPA buffer, and then  proteins were eluted from the 
protein A-Sepharose beads by boiling in 50 pl of Laemmli sample 
buffer for 3 min and analyzed by SDS-polyacrylamide gel electropho- 
resis. Gels  were  fixed in a solution containing 40% methanol and 10% 
acetic acid for 15 min, washed in H,O two times for 10 min each, 
treated with 1 M sodium salicylate for 30 min, and dried for autora- 
diography. For non-denaturing conditions, immunoprecipitations 
were performed exactly as described above except Nonidet P-40 buffer 
(50 mM Tris, pH 8.0, 1% Nonidet P-40, and 1 mM phenylmethylsul- 
fonyl fluoride) containing 150 or 500 mM NaCl was used in place of 
RIPA buffer. 
Purification of Monoclonal  Antibodies-Antibodies  were purified 
from ascites fluid which was raised by injecting nude mice with 
hybridoma supernatants.  4 ml of ascites fluid (approximately 5 mg/ 
ml  of immunoglobulins), was applied to a 1-ml protein A-Sepharose 
(Pharmacia) column equilibrated in buffer containing  3 M NaCl and 
50 mM sodium borate (pH 8.9). The sample was reapplied four times 
and  the column washed with 20 volumes of equilibration buffer. The 
immunoglobulins were eluted with 0.1 M glycine (pH 3.0). Protein 
containing  fractions were  pooled and dialyzed overnight against PBS. 
The protein  concentration was determined by the method of Bradford 
(1976) using bovine immunoglobulins as a  standard. 
Zmmunodepletion-Purified antibodies were conjugated at 3-4  mg/ 
ml of packed Sepharose beads. Antibodies were incubated with cyan- 
ogen bromide-activated Sepharose 2B (Sigma) at  4 "C for 3 h. The 
beads were then removed by centrifugation and washed several times 
with PBS. Unbound sites were  blocked by incubating overnight with 
1 M ethanolamine (pH 8.3). Beads were  removed by centrifugation, 
washed extensively with PBS, and resuspended as a 1:l slurry in 
PBS. 
For immunodepletion, 20 pl of packed immunobeads were  mixed 
with 50 p1 of the nuclear extract, prepared as described previously 
(nuclear  extract/ammonium  sulfate pellet, fraction 1 of the purifica- 
tion, Smith  and Stillman, 1989). Samples were incubated on ice for 1 
h with occasional mixing, and  the beads were  removed  by centrifu- 
gation. 10 p1 of the supernatant was added to a standard SV40 
replication reaction carried out exactly as describedpreviously (Smith 
and Stillman, 1989). The DNA products were isolated and analyzed 
by electrophoresis through a 1% agarose gel as described (Smith  and 
Stillman, 1989). 
Protein samples were processed for immunoblotting. After immu- 
nodepletion, bound proteins were eluted off the immunobeads by 
incubating  in 30 pl of Laemmli sample buffer a t  68 "C for 5 min. The 
depleted supernatants were incubated in Laemmli buffer at 68 "C for 
5 min. An amount corresponding to approximately 33% of the total 
depleted supernatant (15 p1) or 33% of the  total protein bound to  the 
beads (IO pl) was subjected to SDS-polyacrylamide gel electrophoresis 
as described by Laemmli (1970). The gels  were then immunoblotted 
as described above or stained with silver according to  the method of 
Wray et al. (1981). 
RESULTS 
Classification of CAF-I Monoclonal  Antibodies-CAF-I  was 
purified from human 293 cell nuclei as described previously 
(Smith  and  Stillman, 1989) and used to immunize a mouse 
for the production of monoclonal antibodies. The polypeptide 
composition of purified CAF-I is shown in Fig. L4, lane 1. 
CAF-I consists of a large subunit with apparent molecular 
mass of 150,000 (150 kDa),  three polypeptides centered at 60 
kDa, and  a small subunit of 50 kDa (henceforth called p150, 
p60, and p50, respectively). Eight independent monoclonal 
antibodies that recognize individual CAF-I subunits have been 
identified. Immunoblot analysis using these monoclonal an- 
tibodies as probes is presented in Fig. 1B. TWO classes of 
monoclonal antibodies were obtained  the first class reacted 
with p150 and  the second class with the  set of polypeptides 
designated as p60. Immunoblot analysis further showed that 
all of the monoclonal antibodies directed against p60 reacted 
with multiple polypeptides, suggesting that  the 60-kDa triplet, 
identified in the original purified CAF-I, may constitute a 
related  set of proteins (see below). Most of the monoclonal 
antibodies directed against p60 cross-reacted very  weakly with 
a polypeptide of about 50 kDa (data not shown). It is not 
known at this time if this band corresponds to the p50 
contained in the purified CAF-I complex or if it is simply a 
minor proteolytic breakdown product of p60 and  unrelated to 
the p50 subunit of CAF-I. Monoclonal antibodies which re- 
acted exclusively with p50 were not obtained in this mono- 
clonal antibody screen. The eight monoclonal antibodies de- 
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scribed here appear to be independent isolates based upon the 
size of their light chains  (data  not shown) or  their different 
specificites in immunoblotting, immunoprecipitation, and in- 
tracellular staining analyses. Characterization of a  subset of 
the monoclonal antibodies will be described in  detail below 
and a summary of the properties of all eight monoclonal 
antibodies is presented in  Table I. 
Cellular  Localization of CAF-I-The monoclonal antibodies 
were used to determine the intracellular localization of CAF- 
I. When monoclonal antibody 1, which recognizes  p150 (mAb 
p150-1) was used to stain formaldehyde-fixed human Hela 
cells, a nuclear strong staining pattern was observed (Fig. 
2A). Although the  staining  pattern was observed in  all cells 
of the population, the intensity of the  stain varied from cell 
to cell within the population. When the same antibody was 
used to  stain methanol/acetone-fixed cells, it  stained nuclei 
very  weakly and  the  staining was observed in  a  fraction of the 
cells (Fig. 2A) .  Monoclonal antibody 24, which recognizes p60 
(mAb p60-24), produces a staining pattern similar to  that 
shown for mAb p150-1 (Fig. 2B). In contrast, however, a 
strikingly different pattern was obtained  with  a  subset of the 
monoclonal antibodies directed  against p60. A  representative 
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FIG.  1. Immunoblot  analysis of CAF-I  monoclonal  antibod- 
ies. A, purified  CAF-I (glycerol gradient purified; Smith and Stillman 
(1989)) was  subjected to electrophoresis through a 12.5% SDS-poly- 
acrylamide gel, and the proteins were visualized by silver staining. B, 
a partially purified fraction of CAF-I (Mono Q, fraction 6 of the 
purification, Smith and Stillman (1989)) was fractionated on a 12.5% 
SDS-polyacrylamide gel and the proteins transferred to nitrocellu- 
lose. The nitrocellulose was then cut into strips and probed individ- 
ually with each CAF-I  mAb, followed by incubation with rabbit anti- 
mouse  horseradish peroxidase-conjugated immunoglobulins. The im- 
munoblots were  developed as described  under "Materials and Meth- 
ods." The positions of the CAF-I subunits, p150, p60, and p50, are 
shown. 
example is shown in Fig.  2C using mAb p60-3. Like the other 
monoclonal antibodies, mAb p60-3 displayed a  strong nuclear 
stain on formaldehyde-fixed cells (Fig. ZC), but in addition to 
the nuclear stain, a polar perinuclear stain was observed. 
Interestingly, while the nuclear staining  pattern changed in 
methanol/acetone-fixed cells, as it did with the  other mono- 
clonal antibodies, the perinuclear stain was not affected (Fig. 
2C). As a control, a monoclonal antibody directed against 
SV40 T antigen, which is not found in Hela cells, did not 
stain methanol/acetone- or formaldehyde-fixed cells (Fig. 
20). 
CAF-I Polypeptides Are Complexed in Vivo-The mono- 
clonal antibodies were tested for their ability to immunopre- 
cipitate each of the CAF-I polypeptides. In these  initial ex- 
periments  immunoprecipitations were performed using [3sS] 
methionine-labeled 293  cell extracts prepared  in RIPA buffer. 
As a positive control,  a polyclonal mouse antiserum  against 
CAF-I was used to immunoprecipitate the CAF-I polypep- 
tides. As shown in Fig. 3A, lane 1, this antiserum immunopre- 
cipitated the p60 and p150 subunits of CAF-I. Normal mouse 
serum did not immunoprecipitate these proteins (data not 
shown). Fig. 3A, lane 2 shows that  the monoclonal antibody, 
mAb p60-24 immunoprecipitated a polypeptide of approxi- 
mately 60  kDa. The p150 subunit of CAF-I was immunopre- 
cipitated from ["SJmethionine-labeled 293 cells using mAb 
p150-1 (Fig. 3A, lane 3 ) .  The control antibody, mAb p70-9, a 
monoclonal antibody directed against  a 70-kDa polypeptide 
of replication factor  A did not immunoprecipitate the CAF-I 
polypeptides but did precipitate the expected 70-kDa repli- 
cation factor A protein (Fig. 3A, lane 4 ) .  
Under the conditions used for the immunoprecipitation 
analysis shown in Fig.  3A,  p60 did not  appear to be complexed 
with p150, since both polypeptides were not coimmunoprecip- 
itated with the monoclonal antibodies (i.e. mAb p60-24 did 
not coimmunoprecipitate p150). We previously determined 
that CAF-I was a  multisubunit  protein complex, because the 
set of proteins (shown in Fig. IA, lane 1 ) fractionated together 
with  chromatin assembly activity over a wide range of chro- 
matographic steps. This suggested that  the  extract prepara- 
tion conditions shown in Fig. 3A might disrupt this complex. 
We therefore performed the immunoprecipitation analysis 
under less stringent conditions to  try  and preserve the com- 
plex. ["S]Methionine-labeled 293  cell extracts were prepared 
in Nonidet P-40 buffer containing 150 mM NaCl (Fig. 3B, 
lanes 1-4). Under  these conditions, the polyclonal antibody 
precipitated all the CAF-1 subunits, including the p50 subunit 
(lane 1 ), although with the control  antibody there was consid- 
erable background (lane 4 ) .  Under  these low salt conditions, 
the specificity of the mAb  p60-24 and mAb p150-1 precipita- 
tions was difficult to see, particularly for the p60 and p50 
proteins (Fig.  3B, lanes 2 and 3) .  
TABLE I 
Immunological properties of CAF-I monoclonal antibodies 
A summary of the properties of CAF-1 monoclonal antibodies. A + indicates reaction in the indicated assay. 
The blank spaces under immunodepletion indicate not tested. 
Immunoblot mAb CAF-I subunit 
Intracellular 
localization Immunoprecipitation Immunodepletion 
1 p150 + Nuclear + + 
P60 + Nuclear + + 
P60 + Nuclear 
48 p150 + Nuclear 
24 




3 P60 + Nuclear/perinuclear + 
53 P60 + Nuclear/perinuclear + 
75 P60 + Nuclear/perinuclear + 
- 
12044 
FIG. 2. Intracellular localization 
of CAF-I. Hela cells were fixed with 
formaldehyde or methanol/acetone 
(MEOH/Aeetone) and stained with the 
following monoclonal antibodies; mAb 
p150-1 ( A ) ,  mAb p60-24 ( B ) ,  mAb p60- 
3 (C), or pAb 419 (D), followed by in- 
cubation with rabbit anti-mouse horse- 
radish  peroxidase-conjugated immuno- 
globulins. The stain was developed as 
described under “Materials and Meth- 
ods.” 
A 
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The less stringent buffer conditions used in this experiment 
appeared to stabilize the complex but, at  the same time, 
increased the contaminating background proteins. To reduce 
this background, [35S]methionine-labeled 293 cell extracts 
were prepared in Nonidet P-40 buffer containing 500 mM 
NaCl  (Fig.  3B, lanes 5-8). Under these conditions the poly- 
clonal antisera clearly co-precipitated all subunits, the mAb 
p60-24  specifically immunoprecipitated the p50,  p60 and p150 
proteins (lane 6), whereas the control, mAb p70-9, did not 
immunoprecipitate these polypeptides (lane 8). Under these 
high salt conditions, mAb p150-1  was  negative in an immu- 
noprecipitation analysis (lane 7) and only precipitated the 
weaker background bands present in the control (lane 8). 
Moreover, as shown in Fig. 3B, lane 6, under these non- 
denaturing conditions, mAb  p60-24  specifically immunopre- 
cipitated a polypeptide of 50 kDa (note the lower band of the 
doublet  migrating at  the BO-kDa position), whereas the con- 
trol, mAb p70-9,  did not (lane 8). However, additional exper- 
iments will  be required to determine if this 50-kDa  polypep- 
tide corresponds to  the p50 subunit of CAF-I. Nonetheless, 
these data suggest that  the p150 and p60 subunits of CAF-I 
are complexed in uiuo. 
Immunodepletion of Chromatin Assembly Activity in Vitro- 
To confirm that the polypeptides designated as CAF-I were, 
in fact, required  for chromatin assembly activity in uitro, we 
sought to use the CAF-I  monoclonal antibodies in an immu- 
nodepletion  analysis. As described  previously,  CAF-I activity 
was initially identified in a crude nuclear extract that, when 
added to a cytosol replication extract, promoted chromatin 
assembly on replicating DNA (Stillman, 1986; Smith and 
Stillman, 1989). Fig. 4 shows a DNA product analysis of a 
series of replication reactions containing cytosol  replication 
extract, SV40 T antigen, SV40 origin-containingplasmid, and 
nucleoside triphosphates, including [cx-~’P]~ATP. The auto- 
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FIG. 3. Immunoprecipitation of [3SS]methionine-labeled 
CAF-I polypeptides. [:"SS]methionine-labeled 293 cell lysates were 
prepared under ( A )  denaturing  conditions  (in  RIPA buffer) or ( B )  
non-denaturing  conditions  (in  Nonidet  P-40 buffer containing 150 or 
500 mM NaCI) and  immunoprecipitated with  polyclonal mouse anti- 
serum against CAF-I ( P )  or the following monoclonal antibodies; 
mAb p60-24 (24), mAb p150-1 (I), or the  control, mAb p70-9 (9). 
Immunoprecipitated proteins were separated on a 10% SDS-poly- 
acrylamide gel and visualized by fluorography. The positions of the 
CAF-I subunits, p150, p60, and p50, are indicated. 
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Immunodepletion of chromatin assembly acl 
i replication reactions were carried  out in the  absenc 
I ) ,  or presence (lunes 2-5) of nuclear  extract. Nuclear extra 
tivity. 
e (lune 
ct  was 
not precleared (lane 2 )  or was precleared  with the following immu- 
nobeads; mAb p60-24 (lane 3 ) ,  mAb p150-1 (lane 4 ) ,  or mAb 1644 
(lane 5). The DNA  products were  isolated and subjected to electro- 
phoresis  in a 1% agarose gel. A shows  the  autoradiograph  and B the 
ethidium bromide-stained gel. The positions of Form I and Form I I  
DNA are  shown  to  the left. 
radiograph in Fig. 4A shows that DNA replicated in the 
absence of nuclear extract migrated as a covalently closed 
relaxed monomer circle DNA (lane 1 ), whereas the addition 
of the nuclear extract promoted the negative supercoiling of 
the replicated DNA (lane 2). This negative supercoiling re- 
flects assembly of the replicated DNA into chromatin  (Still- 
man, 1986; Smith and Stillman, 1989). The gel was also 
stained with ethidium bromide prior to autoradiography to 
visualize the unreplicated DNA (Fig. 4B).  A comparison of 
the replicated DNA (Fig. 4A, lane 2 )  with the total input 
DNA (Fig.  4B, lane 2), demonstrated that all of the replicated 
DNA was supercoiled, whereas the bulk of the  input DNA 
remained relaxed. This confirms that chromatin assembly in 
this system occurs preferentially if not exclusively on repli- 
cated DNA. 
Preliminary  experiments  demonstrated that neither mAb 
p150-1 or mAb p60-24 inhibited replication dependent  chro- 
nue.ext. + + + 4 
mAb - 24 I 1644 
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FIG. 5. Analysis of the proteins in the immunodepleted ex- 
tracts. Nuclear extract was preincubated with the specific immuno- 
beads  containing  the  indicated monoclonal antibody covalently at- 
tached to Sepharose  and  then  fractionated  into  supernatants ( S )  and 
pellets (P). A sample of the  protein was  subjected to electrophoresis 
through 10% SDS-polyacrylamide  gels and visualized by silver stain- 
ing ( A )  or  transferred  to nitrocellulose and  immunoblotted with mAb 
p150-1 ( B )  as described under "Materials and Methods." Nuclear 
extract was not  preincubated (lune I ) or was preincubated with the 
following immunobeads; mAb p60-24 (lunes 2 and 3 ) ,  mAb p150-1 
(lanes 4 and 5), mAb 1644 (lunes 6 and 7) and separated into 
supernatant ( S )  and  pellet ( P )  fractions. Note that  the  precipitates 
were not washed prior to electrophoresis, and consequently, the silver 
stain of the gel shows many  nuclear  proteins. 
matin assembly in uitro if they were added directly to  the 
reaction (data  not shown). Therefore, each of the monoclonal 
antibodies were covalently coupled to Sepharose beads and 
immunodepletion was performed by preincubating the nuclear 
extract with the immunobeads on ice for 60 min. Following 
the preincubation, the immunobeads were removed by cen- 
trifugation and  the depleted supernatant was then added to 
the replication reaction. As shown in  Fig.  4, preclearing of the 
nuclear extract with mAb p60-24 beads (lane 3 )  or mAb 
p150-1 beads (lane 4 )  depleted the extract of most of the 
chromatin assembly activity. In contrast, preclearing of the 
nuclear extract with Sepharose beads coupled to a monoclonal 
antibody directed against  human DNA polymerase a (mAb 
1644) had no effect (lane 5 ) .  Note that in this case, polymerase 
a for replication was provided by the cytosol replication 
extract. 
To confirm that  the immunodepletion actually removed the 
CAF-I polypeptides from the nuclear extract, the depleted 
extracts were analyzed by immunoblotting. After the prein- 
cubation  step,  proteins  contained  in the depleted supernatants 
or proteins bound to  the immunobeads were analyzed by SDS- 
polyacrylamide gel electrophoresis, transferred to nitrocellu- 
lose, and probed with mAb p150-1. Direct analysis of the 
proteins  in each sample by silver staining revealed few,  if any, 
differences (Fig. 5A).  In  contrast, however, immunoblot analy- 
sis (Fig. 5B) showed that  the mAb p60-24-depleted (lane 2 )  
or mAb pl50-depleted (lane 4 )  depleted supernatants, which 
were both inactive for chromatin assembly, contained reduced 
amounts of the p150 subunit of CAF-I. In contrast, the mAb 
1644-depleted supernatant, which was still active in chroma- 
tin assembly, showed no reduction in the amount of p150 
(lane 6). Accordingly,  p150  was found bound to  the mAb p60- 
24 immunobeads (lane 3 )  and  the mAb p150-1 immunobeads 
(lane 5 )  but not the mAb 1644 immunobeads (lune 7). These 
data confirm that p60 and p150 are  part of the CAF-I complex 
12046 Chromatin Assembly in Vitro 
A B 
mAb 24 I 419  24 
m m 
1 2  1 2  
- PI50 - 
FIG. 6. Immunoprecipitation of ["2P]phosphate-labeled 
CAF-I polypeptides. A ,  [:"P]phosphate-labeled 293 cell lysates were 
prepared under denaturing conditions (in RIPA buffer) and immu- 
noprecipitated with mAb p60-24 (lane 1 )  or  mAb p150-1 (lane 2) .  B, 
[:'ZP]phosphate-labeled 293 cell lysates were prepared under non- 
denaturing conditions (in Nonidet P-40 buffer containing 500 nM 
NaCI)  and  immunoprecipitated with pAB 419 (lane I )  or  mAb p60- 
24 (lane 2). Immunoprecipitated proteins were separated by electro- 
phoresis through 10% SDS-polyacrylamide and autoradiographed. 
The positions of the CAF-I subunits p150 and p60 are shown. 
and demonstrate that  they  are required for chromatin assem- 
bly activity in uitro. 
Post-translational Modification of CAF-I-As shown in  the 
immunoblot analysis  presented  in Fig. lB, all of the mono- 
clonal antibodies directed against the p60 subunit of CAF-I 
reacted with multiple polypeptides, suggesting that these  pro- 
teins shared  a common epitope. In  contrast, however, immu- 
noprecipitation analysis of ["S]methionine-labeled cells with 
the same monoclonal antibodies yielded only one or possibly 
two polypeptides (Fig. 3A, lane 1 and  data  not shown). These 
data suggested the possibility that  the multiple polypeptides 
were a result of a post-translational modification, such as 
phosphorylation, which was not being detected  in the [?3] 
methionine-labeled cell extracts. To  test  this possibility, ["PI 
phosphate-labeled 293 cell extracts were prepared  under  de- 
naturing conditions (in RIPA buffer). As shown in Fig. 6A, 
lane 1, a "'P-labeled protein of approximately 60 kDa was 
immunoprecipitated with mAb  p60-24. Interestingly, immu- 
noprecipitation with mAb p150-1 (Fig. 6A, lane 2) ,  revealed 
that the p150 subunit of CAF-I was also phosphorylated. 
When [:12P]phosphate-labeled 293  cell extracts were prepared 
under non-denaturing conditions (in Nonidet P-40 buffer 
containing 500 mM NaCl), mAb p60-24 immunoprecipitated 
"'P-labeled  p60 and p150  (Fig.  6B, lane 2), whereas the con- 
trol, pAb  419, a monoclonal antibody directed against SV40 
T antigen, did not immunoprecipitate these polypeptides (Fig. 
6B, lane 1). These data show that both the p60 and  the p150 
subunits of CAF-I are phosphorylated in  the cell and again 
confirm that these subunits  are complexed in uiuo. 
DISCUSSION 
In  this report we describe the isolation of a  panel of mono- 
clonal antibodies directed against the human replication- 
dependent  chromatin assembly factor, CAF-I. As a first  step 
toward investigating the mechanism and regulation of CAF- 
I, we have used these monoclonal antibodies to characterize 
some of the properties of CAF-I in uiuo. The classification of 
the eight monoclonal antibodies as independent isolates is 
based upon their immunochemical properties, which are sum- 
marized in Table I. In cases where the monoclonal antibodies 
behaved identically in all assays tested,  they were designated 
as independent isolates based upon differences in the migra- 
tion of the light and heavy chains of the purified immuno- 
globulins during SDS-polyacrylamide gel electrophoresis and/ 
or subtle differences in the  pattern obtained  in the immuno- 
blot analysis. 
Cell staining  analysis  with  all of the monoclonal antibodies 
showed an intranuclear localization of CAF-I. This was not 
surprising because the protein was initially purified from 
nuclei, and in  addition,  a nuclear localization pattern is con- 
sistent with CAF-I function in uitro; replication coupled chro- 
matin assembly. A strong nuclear staining  pattern was ob- 
tained only after cells were fixed with formaldehyde. Inter- 
estingly, under  these conditions, although CAF-I was present 
in  the nucleus of all the cells in the population, the intensity 
of the  stain varied from cell to cell within the population. 
Immunostaining of cells fixed with methanol/acetone showed 
only a very weak nuclear stain  and only in  a  fraction of the 
total cell population. The cells used in this study  represent 
an actively growing unsynchronized population and thus, 
should contain cells in all stages of the cell  cycle. This raises 
the intriguing possibility that  the heterogeneous staining  pat- 
tern reflects differences in the  amount or localization of CAF- 
I  during the cell  cycle, although extensive cell cycle studies 
will  be required to investigate this further. 
Surprisingly, in addition to the nuclear staining pattern 
described above, a perinuclear stain was observed using a 
subset of the CAF-I monoclonal antibodies directed against 
p60. The polar, perinuclear staining pattern is reminiscent of 
proteins that localize to  the Golgi apparatus and/or endo- 
plasmic reticulum; however, electron microscopic analysis will 
be required to determine  this. That these monoclonal anti- 
bodies actually recognized the p60 subunit of the CAF-I 
complex was confirmed by using immunoprecipitation analy- 
sis  to demonstrate that each mAb that showed a perinuclear 
staining  pattern also coimmunoprecipitated the p150 subunit 
of the CAF-I complex (data not shown). The possibility still 
exists, however, that these monoclonal antibodies simply rec- 
ognize a common epitope shared by the CAF-I p60 subunit 
and  an unrelated perinuclear protein. This can  be addressed 
by mapping the epitopes that these monoclonal antibodies  are 
directed against. If this perinuclear antigen is in  fact CAF-I, 
it will  be interesting to determine if this localization reflects 
a storage, modification, or assembly site for CAF-I. 
The monoclonal antibody screen described in this paper 
yielded isolates that recognized two of the  three components 
of the CAF-I complex: the p60 triplet  and  the p150 subunit. 
We did not, however, obtain monoclonal antibodies  against 
the p50 subunit. Although the protein preparation used to 
immunize the mouse contained  similar amounts of all three 
components, an immunoprecipitation analysis using the pol- 
yclonal mouse antiserum showed only a very weak response 
to p50 (see Fig. 3A, lane I ) ,  which could explain why no 
monoclonal antibodies were obtained. The demonstration, 
however, that a 50-kDa peptide was coimmunoprecipitated by 
mAb  p60-24 does suggest that p50 is contained  in the CAF-I 
complex. Further characterization of the p50 subunit will 
await the isolation of monoclonal antibodies which specifi- 
cally react  with it  and/or two-dimensional gel analysis of the 
proteins  in the CAF-I complex. 
The initial designation of CAF-I as a  multisubunit  protein 
complex was based upon cofractionation of a set of polypep- 
tides with chromatin assembly activity (Smith  and Stillman, 
1989). The use of the monoclonal antibodies directed against 
CAF-I in the immunodepletion analysis described here served 
to confirm that p60 and p150 are contained in a complex 
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which is required for chromatin assembly activity in vitro. 
Interestingly, while  mAb p150-1 completely depleted the  nu- 
clear extract of p150, mAb p60-24 effected only a partial 
depletion of p150. Yet, in  both cases, the chromatin assembly 
activity was depleted. Immunodepletion with mAb p60-24 
may have disrupted the CAF-I complex, leaving inactive p150 
in  the extract. Alternatively, the nuclear extract may contain 
a fraction of  p15O which is  not  part of the CAF-I complex and 
is inactive in chromatin assembly. An example of this has 
recently been described for the cdcZhuman protein  kinase (the 
homologue of the C C E C ~ ~ " ~  protein  kinase), which is found in 
the cell in at least two forms: as an active kinase in  a complex 
with other protein subunits or free of these subunits and 
inactive as  a  protein  kinase  (Draetta and Beach, 1988). Ad- 
ditional  experiments using biochemical fractionation and im- 
munoblotting analysis can be done to characterize the  state 
of the individual subunits of CAF-I as they exist in vivo. 
Recent studies on the mechanism of chromatin assembly 
during DNA replication have demonstrated that histones  are 
assembled onto  the DNA in  a  sequential  manner  (Smith  and 
Stillman, 1991). In the first step, histones H3  and H4 are 
assembled onto  the DNA during DNA replication in  a CAF- 
1-dependent manner. Subsequently, histones H2A and H2B 
are loaded onto the DNA to complete the chromatin  structure. 
These studies, and those described in  this report,  demonstrate 
that CAF-I plays an essential role in  chromatin assembly and, 
therefore, may be a  target for regulation during the cell cycle. 
We have shown that both the p60 and  the p150 subunits of 
CAF-I are phosphorylated. The function of this phosphoryl- 
ation  is unknown; however, several possibilities can be ex- 
plored. Phosphorylation of CAF-I could be restricted to a 
specific time  during the cell cycle associated with DNA rep- 
lication as has recently been demonstrated for replication 
factor A, a  multisubunit replication factor that is specifically 
phosphorylated during the S phase of the cell cycle (Din et 
al., 1990). Phosphorylation in S phase could function in 
several ways: to localize proteins to specific regions of the 
nucleus, to regulate complex formation of a multisubunit 
protein,  or to control the biochemical activity of a  protein. 
With respect to this last  point, we have previously shown that 
CAF-I binds  histones in  vitro (Smith  and  Stillman, 1989), a 
property which could be modulated by phosphorylation. Along 
these lines, it is interesting to note that  the Xenopus chro- 
matin assembly factor, nucleoplasmin, which binds  histones 
in vitro (Laskey et al., 1978; Earnshaw et al., 1980) and in viuo 
(Dilworth et al., 1987), becomes phosphorylated during devel- 
opment, coincident with an increase in chromatin assembly 
activity (Cotten et al., 1986; Sealy et al., 1986). Thus,  it will 
be important to determine if the phosphorylation state of 
CAF-I effects its ability to bind histones and/or assemble 
chromatin in  vitro. 
In  this report we describe the initial  characterization of a 
panel of monoclonal antibodies directed against the human 
replication-dependent chromatin assembly factor, CAF-I. The 
ability to use these monoclonal antibodies across the wide 
range of techniques described here will permit an investiga- 
tion of the function of CAF-I both in  vitro and in viuo, with 
the ultimate goal of understanding how chromatin is assem- 
bled during DNA replication in eukaryotic cells. 
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